Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
Deloitte
AstraZeneca
Cantor Fitzgerald
Moodys

Generated: May 26, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: rufinamide

« Back to Dashboard

rufinamide

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai Inc BANZEL rufinamide SUSPENSION;ORAL 201367 NDA Eisai Inc. N 62856-584-46
Eisai Inc BANZEL rufinamide TABLET;ORAL 021911 NDA Eisai Inc. N 62856-582-52
Eisai Inc BANZEL rufinamide TABLET;ORAL 021911 NDA Eisai Inc. N 62856-583-52
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cipla
Daiichi Sankyo
Mallinckrodt
Baxter
QuintilesIMS
Queensland Health
US Department of Justice
Colorcon